Market Cap (In TWD)
476.57 Million
Revenue (In TWD)
280.54 Million
Net Income (In TWD)
-2.64 Million
Avg. Volume
13.4 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 22.0-39.4
- PE
- 409.0
- EPS
- 0.05
- Beta Value
- 0.343
- ISIN
- TW0006661002
- CUSIP
- -
- CIK
- -
- Shares
- 23304200.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Dr. Yi Xing Lin
- Employee Count
- -
- Website
- https://www.welgene.com.tw
- Ipo Date
- 2017-10-23
- Details
- Welgene Biotech Co.,Ltd. provides genetic testing services. The company offers research services, including sequencing, microarray, qPCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and Cytoscan, an array-based comparative genomic hybridization. It also provides reagents, consumable supplies, and instruments, as well as software services. The company was founded in 2003 and is based in Taipei City, Taiwan.
More Stocks
-
1663
-
FONRFONAR Corporation
FONR
-
9988
-
003920
-
CTAGFCapita plc
CTAGF
-
ASMB
-
PBCO
-
7844Marvelous Inc.
7844